644 studies found for:    hgh
Show Display Options
Rank Status Study
21 Not yet recruiting Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF
Condition: Female Infertility Due to Diminished Ovarian Reserve
Interventions: Drug: Human Growth Hormone;   Drug: Follicle Stimulating Hormone
22 Completed Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Pegylated-Somatropin in Healthy Volunteers
Condition: Healthy
Interventions: Drug: Pegylated-Somatropin;   Drug: YPEG-Somatropin
23 Withdrawn Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton®
Condition: Growth Hormone Deficiency
Intervention: Drug: Somatropin
24 Completed Growth Hormone to Increase Immune Function in People With HIV
Condition: HIV Infections
Intervention: Drug: Somatropin (recombinant human growth hormone)
25 Recruiting Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Condition: Pediatric Growth Hormone Deficiency
Interventions: Drug: MOD-4023;   Drug: Somatropin
26 Terminated Clinical Trial of Growth Hormone in MPS I, II, and VI
Condition: Mucopolysaccharidosis Type I, II, and VI.
Intervention: Drug: Somatropin (DNA origin)
27 Completed
Has Results
Long Term Use of Somatropin in Patients Small for Gestational Age
Condition: Small for Gestational Age
Intervention: Drug: Somatropin
28 Completed
Has Results
Growth Hormone in Neuroendocrine Dysfunction With Severe Fibromyalgia Syndrome
Condition: Fibromyalgia
Interventions: Drug: Saizen®;   Drug: Placebo and Saizen®
29 Active, not recruiting Observational Study of Somatropin Treatment in Children
Conditions: Dwarfism, Growth Hormone Deficiency;   Turner Syndrome;   Infant, Small for Gestational Age;   SHOX Protein, Human
Intervention: Drug: Somatropin (rDNA origin)
30 Completed Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children
Condition: Growth Hormone Deficiency
Intervention: Biological: PEG-somatropin
31 Completed
Has Results
Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
Condition: Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
Intervention: Biological: Serostim
32 Completed
Has Results
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
Conditions: Acromegaly;   Growth Hormone Deficiency;   Pituitary Disease
Interventions: Drug: Recombinant human growth hormone;   Drug: Saline
33 Completed
Has Results
Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children;   Foetal Growth Problem;   Small for Gestational Age;   Genetic Disorder;   Turner Syndrome;   Chronic Kidney Disease;   Chronic Renal Insufficiency;   Delivery Systems
Intervention: Drug: Norditropin NordiFlex®
34 Completed Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)
Conditions: Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS);   Human Immunodeficiency Virus Infections
Interventions: Drug: Serostim®;   Drug: Placebo
35 Completed Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children
Condition: Growth Hormone Deficiency
Interventions: Drug: pegylated Somatropin;   Drug: Jintropin AQ
36 Completed
Has Results
Somatropin Treatment to Final Height in Turner Syndrome
Condition: Turner Syndrome
Interventions: Drug: Somatropin;   Drug: Ethinyl estradiol;   Drug: Medroxyprogesterone acetate
37 Active, not recruiting
Has Results
Growth Hormone as a Determinant of Weight Regulation
Condition: Obesity
Interventions: Other: overfeeding;   Drug: growth hormone treatment
38 Completed Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates
Condition: Growth Hormone Deficiency
Interventions: Drug: Growth hormone (Genotropin);   Drug: Placebo
39 Completed A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency
Condition: Growth Hormone Deficiency
Interventions: Drug: hGH-ViaDerm™ System (hGH or somatropin);   Device: hGH-ViaDerm™ System
40 Enrolling by invitation Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTON
Condition: Growth Hormone Deficiency
Intervention: Other: Growth hormone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years